Home Data Calendar Blog

REGN

Tables

2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31

Weighted Average Number Of Diluted Shares Outstanding 115.10 NA 113.40 113.90 114.00 NA 112.80 114.00 113.10 NA 113.90 110.80 110.50 NA 113.90 117.90 115.10 NA 114.20 114.60 115.50 NA 115.09 114.48 114.91 NA 117.03 116.14 115.11 NA 116.47 116.23 114.23 NA 115.94 115.26 114.52 NA 117.42 113.03 112.15 NA 116.71 111.06 109.37 NA 115.83 110.17 107.73 NA 91.05 90.44 89.16 NA NA NA NA

Weighted Average Number Of Shares Outstanding Basic 107.80 NA 106.30 107.00 107.10 NA 106.90 107.90 106.80 NA 106.20 105.00 105.40 NA 105.50 109.60 109.80 NA 109.40 109.20 108.90 NA 108.03 107.80 107.65 NA 106.71 106.03 105.57 NA 104.83 104.63 104.29 NA 103.35 102.89 102.23 NA 100.80 100.39 98.71 NA 98.23 97.70 96.88 NA 95.01 94.59 93.45 NA 91.05 90.44 89.16 NA NA NA NA

Earnings Per Share Basic 6.70 10.89 9.48 9.05 7.64 11.21 12.31 7.90 9.12 20.98 15.37 29.51 10.58 10.90 7.98 8.19 5.69 7.25 6.12 1.77 4.23 7.58 5.50 5.12 4.44 1.62 3.64 3.66 2.36 2.41 2.53 1.88 1.59 1.49 2.04 1.89 0.74 1.09 0.79 0.92 0.66 0.98 1.44 0.89 1.02 4.92 2.02 0.81 0.12 -0.58 -0.68 -0.69 -0.49 NA NA NA NA

Earnings Per Share Diluted 6.27 10.20 8.89 8.50 7.17 10.49 11.66 7.47 8.61 19.68 14.33 27.97 10.09 10.24 7.39 7.61 5.43 6.93 5.86 1.68 3.99 7.15 5.17 4.82 4.16 1.50 3.32 3.34 2.16 2.19 2.27 1.69 1.45 1.34 1.82 1.69 0.66 0.96 0.70 0.82 0.58 0.86 1.25 0.79 0.90 4.08 1.72 0.70 0.11 -0.58 -0.68 -0.69 -0.49 NA NA NA NA

2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31

Revenue From Contract With Customer Excluding Assessed Tax 3145.00 3434.30 3362.70 3158.10 3162.10 3414.40 2936.20 2857.20 2965.10 4951.70 3452.80 5138.50 2528.70 2422.90 2294.00 1952.00 1828.20 2169.50 2048.40 1933.70 1711.80 1927.80 1663.50 1608.02 1511.50 1582.40 1500.67 1470.12 1319.00 1226.83 1220.12 1212.63 1200.85 1098.08 1137.42 998.62 869.61 802.33 725.79 665.70 625.74 610.41 597.03 457.64 439.66 414.60 427.69 304.40 231.79 122.98 102.83 107.81 112.20 133.68 105.98 115.89 103.53

Revenues 3145.00 3434.30 3362.70 3158.10 3162.10 3414.40 2936.20 2857.20 2965.10 4951.70 3452.80 5138.50 2528.70 2422.90 2294.00 1952.00 1828.20 2169.50 2048.40 1933.70 1711.80 1927.80 1663.50 1608.02 1511.48 1582.45 1500.67 1470.12 1318.99 1226.83 1220.12 1212.63 1200.85 1098.08 1137.42 998.62 869.61 802.33 725.79 665.70 625.74 610.41 597.03 457.64 439.66 414.60 427.69 304.40 231.79 122.98 102.83 107.81 112.20 133.68 105.98 115.89 103.53

Costs And Expenses 2393.60 2461.40 2251.70 2141.60 2215.40 2267.60 1712.50 1747.30 1706.60 2312.00 1605.60 1791.30 1416.00 1255.90 1240.90 1295.60 1128.10 1493.80 1309.90 1618.10 1231.80 1209.70 1036.57 985.83 944.25 1043.64 940.75 919.80 888.45 879.82 857.32 921.00 871.54 867.00 745.00 653.76 586.06 586.53 543.07 443.29 439.80 398.34 360.23 299.54 286.61 268.93 225.32 216.92 209.59 168.38 161.29 168.13 153.19 146.45 138.07 139.61 132.41

Research And Development Expense 1248.40 1177.20 1075.30 1085.30 1101.20 1043.10 911.30 794.30 843.80 785.60 665.40 714.20 742.90 744.50 684.60 722.00 583.90 683.10 663.40 1048.30 641.80 601.25 556.97 529.29 498.59 527.98 529.75 509.98 507.44 479.21 543.05 559.93 470.11 461.21 425.92 390.33 343.11 351.75 337.73 294.50 287.38 268.14 224.04 187.46 180.30 181.02 158.29 147.37 138.86 129.04 127.92 143.15 129.39 125.21 122.04 124.53 117.47

Selling General And Administrative Expense 689.00 737.70 640.50 652.00 601.10 660.50 529.10 476.30 450.00 559.60 445.00 414.70 405.60 303.50 326.90 348.30 367.30 586.80 419.90 417.30 410.80 491.31 369.23 364.88 330.77 409.91 306.77 306.91 296.85 325.94 270.05 292.04 289.68 294.95 209.99 174.59 158.99 175.31 149.75 102.41 108.85 82.08 97.61 72.46 77.26 57.74 46.88 47.70 58.43 36.35 32.92 24.59 23.41 20.64 15.66 14.68 14.22

Operating Income Loss 751.40 972.90 1111.00 1016.50 946.70 1146.80 1223.70 1109.90 1258.50 2639.70 1847.20 3347.20 1112.70 1167.00 1053.10 656.40 700.10 675.70 738.50 315.60 480.00 718.06 626.92 622.19 567.23 538.81 559.93 550.31 430.54 347.00 362.80 291.63 329.31 231.08 392.42 344.86 283.55 215.80 182.72 222.41 185.94 212.07 236.80 158.10 153.05 145.67 202.36 87.48 22.20 -45.40 -58.46 -60.32 -40.98 -12.78 -32.09 -23.72 -28.88

Interest Expense 16.10 18.30 17.80 18.90 18.00 17.40 15.30 13.10 13.60 14.10 14.20 14.40 14.60 14.80 26.30 9.70 6.10 6.70 7.80 8.00 7.70 7.35 7.49 6.92 6.44 6.02 6.18 5.40 7.50 NA NA NA NA 3.61 1.72 2.75 6.17 6.35 9.23 10.18 11.61 11.66 11.74 11.37 11.68 11.49 11.41 11.24 11.16 9.46 4.06 4.05 3.72 2.46 2.23 2.34 2.08

Income Tax Expense Benefit -21.30 -12.00 103.00 114.50 40.20 127.60 194.10 111.10 87.60 274.40 184.40 653.90 137.80 75.40 156.20 21.60 44.00 97.80 98.90 31.60 85.00 -144.19 41.21 104.66 107.42 381.25 177.29 138.11 183.36 88.41 101.08 96.04 164.41 72.30 182.89 133.35 200.50 99.63 96.36 110.38 109.82 101.35 84.38 60.32 42.96 -335.80 NA 0.00 NA -0.61 0.56 -0.86 -0.22 0.00 0.00 0.00 0.00

Other Comprehensive Income Loss Net Of Tax 3.70 NA 20.90 -16.10 57.20 NA -51.30 -53.70 -143.90 NA -6.20 -0.50 -13.10 NA -4.70 44.60 -30.20 NA 0.70 13.00 15.10 NA 1.10 4.10 -9.70 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Net Income Loss 722.00 1159.60 1007.80 968.40 817.80 1197.10 1315.70 852.10 973.50 2229.00 1632.20 3098.90 1115.20 1149.20 842.10 897.30 624.60 792.00 669.60 193.10 461.10 820.40 594.65 551.41 477.98 173.52 388.32 387.74 248.93 253.12 264.80 196.22 165.74 154.99 210.40 194.64 76.02 110.18 79.72 92.73 65.44 96.81 141.31 87.38 98.87 470.41 191.47 76.74 11.65 -53.44 -62.37 -62.51 -43.45 -14.60 -33.88 -25.47 -30.52

Comprehensive Income Net Of Tax 725.70 1255.50 1028.70 952.30 875.00 1233.40 1264.40 798.40 829.60 2193.30 1626.00 3098.40 1102.10 1147.70 837.40 941.90 594.40 796.60 670.30 206.10 476.20 818.62 595.75 555.39 468.34 150.32 409.80 395.98 255.89 243.17 256.70 197.06 161.53 155.84 198.97 165.89 71.67 135.53 102.35 95.53 68.10 98.47 141.88 85.59 98.40 471.14 191.94 75.71 12.18 -53.57 -63.19 -61.23 -43.13 -16.91 -33.74 -26.50 NA

2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31

Assets 34369.60 33080.20 32163.30 30657.50 30059.90 29214.50 27677.80 27205.80 26348.70 25434.80 23671.50 21485.90 17772.20 17163.30 16084.00 14428.70 15757.50 14805.20 13939.30 13173.60 12854.80 11734.50 10805.61 9951.98 9372.70 8764.29 8701.22 8106.37 7817.36 6973.47 6828.02 6204.91 5904.46 5609.13 5182.91 4526.97 4198.57 3871.83 3739.42 3456.08 3260.40 2951.01 2640.41 2378.26 2276.00 2080.49 1660.62 1457.50 1350.16 1323.58 983.03 1046.86 1074.29 1089.43 NA NA NA

Liabilities 7378.50 7107.10 7258.90 6639.60 6564.70 6550.50 6239.00 6518.00 6434.00 6666.00 6413.50 6358.60 5795.20 6138.00 5958.50 5371.30 3624.50 3715.50 3434.90 3417.70 3410.10 2977.20 2937.31 2765.55 2805.05 2620.21 2649.62 2585.64 2951.34 2524.22 2336.77 2128.40 2139.38 1954.30 1886.05 1188.51 1227.14 1329.50 1187.63 1087.24 1049.15 998.94 950.24 884.92 869.65 835.11 854.59 862.84 846.13 837.85 554.78 568.83 556.20 561.62 NA NA NA

Liabilities And Stockholders Equity 34369.60 33080.20 32163.30 30657.50 30059.90 29214.50 27677.80 27205.80 26348.70 25434.80 23671.50 21485.90 17772.20 17163.30 16084.00 14428.70 15757.50 14805.20 13939.30 13173.60 12854.80 11734.50 10805.61 9951.98 9372.70 8764.29 8701.22 8106.37 7817.36 6973.47 6828.02 6204.91 5904.46 5609.13 5182.91 4526.97 4198.57 3871.83 3739.42 3456.08 3260.40 2951.01 2640.41 2378.26 2276.00 2080.49 1660.62 1457.50 1350.16 1323.58 983.03 1046.86 1074.29 1089.43 NA NA NA

Stockholders Equity 26991.10 25973.10 24904.40 24017.90 23495.20 22664.00 21438.80 20687.80 19914.70 18768.80 17258.00 15127.30 11977.00 11025.30 10125.50 9057.40 12133.00 11089.70 10504.40 9755.90 9444.70 8757.30 7868.30 7186.43 6567.64 6144.08 6051.59 5520.74 4866.02 4449.24 4491.25 4076.51 3765.08 3654.84 3296.87 3338.46 2971.43 2542.32 2551.79 2368.84 2211.25 1952.08 1690.17 1493.34 1406.35 1245.38 806.02 594.66 504.02 485.73 428.25 478.03 518.09 527.82 348.06 371.22 386.27

2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31

Assets Current 18871.50 19479.20 18634.80 16923.00 16909.20 15884.10 15428.60 15529.90 14306.00 14014.90 13775.40 13337.60 10055.10 9779.10 9097.60 7860.20 8644.10 7689.10 7109.10 6651.00 6928.60 6447.60 5719.58 4814.92 4544.73 4335.03 4135.74 3860.05 3669.26 3180.19 3501.69 3209.22 3133.38 2915.09 2675.64 2283.34 2310.71 2167.46 2200.51 1918.69 1871.05 1796.93 1634.16 1561.36 1307.12 1206.01 948.60 769.19 696.91 652.88 339.87 413.27 325.50 357.62 NA NA NA

Cash And Cash Equivalents At Carrying Value 2602.00 2730.00 2152.30 1937.20 3916.30 3105.90 3491.30 3395.10 3345.70 2885.60 3432.40 2072.20 1437.90 2193.70 1573.00 1992.20 2208.20 1617.80 1384.80 1045.50 1708.50 1467.70 1087.84 917.88 1019.49 812.73 792.07 744.31 811.77 535.20 920.36 646.51 604.21 809.10 654.59 390.55 507.91 648.72 646.55 600.13 461.86 535.61 263.21 381.68 180.36 230.28 119.00 171.94 394.58 483.61 206.40 254.31 135.38 112.57 325.29 112.00 117.31

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 2609.80 2737.80 2160.20 1949.70 3928.80 3119.40 3504.80 3408.60 3359.20 2898.10 3444.90 2084.70 1450.40 2207.30 1586.60 2004.70 2220.70 1630.30 1397.30 1058.00 1721.00 1480.20 1100.34 930.38 1031.99 825.23 804.57 756.81 824.27 547.70 NA NA NA 809.10 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Marketable Securities Current 7917.50 8114.80 7761.30 6990.50 5043.40 4636.40 3530.40 4171.30 3704.90 2809.10 2355.20 1838.60 2065.90 1393.30 1452.90 1152.00 1795.20 1596.50 1493.10 1624.20 1523.90 1342.20 1104.31 765.64 605.46 596.85 586.88 523.54 495.31 503.48 488.03 398.66 244.97 236.12 241.06 213.69 234.26 251.76 395.65 216.77 186.28 158.38 182.11 155.83 127.35 77.82 143.55 129.08 37.71 43.33 39.10 55.37 91.06 136.80 NA NA NA

Accounts Receivable Net Current 5222.20 5667.30 5584.50 5121.30 5118.60 5328.70 5548.30 5161.40 4839.00 6036.50 5452.00 6998.60 4173.00 3111.50 3092.50 1991.00 2063.10 2100.00 2027.70 1920.20 1728.40 1723.70 1665.74 1534.32 1531.94 1538.64 1532.69 1420.40 1339.79 1343.37 1332.07 1431.97 1450.57 1152.49 1088.21 1071.66 1015.96 739.38 673.91 664.08 801.77 787.07 855.84 767.87 703.86 593.21 506.68 349.64 159.46 28.25 3.66 2.92 3.77 13.51 NA NA NA

Inventory Net 2714.90 2580.50 2562.00 2507.70 2424.70 2401.90 2412.20 2218.50 1991.50 1951.30 2053.80 1983.90 2164.70 1916.60 1801.60 1640.90 1480.90 1415.50 1344.30 1317.20 1208.80 1151.20 1039.68 928.55 820.40 726.14 641.59 554.32 466.58 399.36 345.62 316.07 303.29 238.58 190.67 171.27 133.86 128.86 120.32 109.90 86.55 70.35 63.29 57.16 43.98 28.64 29.57 10.50 6.20 3.50 NA NA NA NA NA NA NA

Prepaid Expense And Other Assets Current 414.90 386.60 574.70 366.30 406.20 411.20 446.40 583.60 424.90 332.40 482.00 444.30 213.60 160.80 230.60 263.80 226.60 387.10 226.90 208.20 182.20 243.30 284.81 163.60 155.45 224.97 143.76 193.33 146.06 130.53 103.81 96.02 115.69 163.50 89.49 43.10 34.10 71.49 61.73 60.67 52.25 96.14 156.84 108.91 97.14 56.66 84.78 32.79 26.27 22.90 15.93 19.03 NA 15.14 NA NA NA

Available For Sale Securities Debt Securities 14115.00 12533.90 12620.40 12290.00 10051.30 10018.20 8369.60 9712.10 9750.20 8397.20 6614.90 4337.60 4607.20 3689.10 3550.40 2934.50 4469.60 4234.50 4176.00 4094.80 3733.00 3009.20 2834.21 2724.76 2358.37 2020.56 1826.14 1527.85 1408.36 1318.52 1203.72 917.82 778.76 836.82 894.83 757.16 627.98 613.10 789.56 760.62 717.43 547.10 509.73 326.86 479.53 351.56 461.64 422.99 296.90 322.14 301.33 310.38 NA 510.28 NA NA NA

2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31

Intangible Assets Net Excluding Goodwill 1058.70 1038.60 1017.20 953.00 928.70 915.50 804.10 NA NA 6.70 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Other Assets Noncurrent 470.20 444.10 409.90 393.20 349.60 336.40 320.20 269.90 262.00 222.80 145.90 142.90 145.70 168.10 168.80 175.50 161.20 144.70 137.90 139.80 144.30 127.40 125.20 85.67 78.98 77.87 36.62 36.96 37.09 20.29 20.70 6.71 5.79 5.81 4.58 4.14 4.47 3.03 3.42 8.88 5.34 5.33 4.41 15.21 20.08 23.10 18.32 19.57 20.39 19.14 13.02 12.29 10.23 6.79 NA NA NA

Available For Sale Debt Securities Amortized Cost Basis 14212.70 12636.00 12843.50 12539.40 10280.80 10320.10 8716.30 9994.40 9965.10 8428.70 6600.90 4315.50 4584.10 3649.20 3508.30 2890.30 4478.00 4206.30 4148.90 4073.70 3730.20 3026.60 2851.52 2743.03 NA 2027.27 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31

Liabilities Current 3580.90 3423.40 3598.60 3104.40 3100.10 3141.30 2879.20 3033.90 3007.60 3932.50 3714.80 3732.40 3217.80 2697.40 2337.80 3702.40 2055.20 2096.60 1765.40 1713.10 1511.40 1442.80 1417.23 1331.19 1265.74 1135.48 1138.63 1029.02 1308.27 1241.49 961.18 951.56 919.72 811.16 734.99 601.54 536.13 654.66 410.20 351.58 305.07 298.83 268.73 203.80 197.24 163.55 178.57 183.22 160.39 148.27 133.24 135.87 112.25 109.06 NA NA NA

Accounts Payable Current 671.30 606.60 536.60 547.30 599.50 589.20 NA NA NA 564.00 NA NA NA 475.50 NA NA NA 418.10 NA NA NA 218.20 NA NA NA 178.20 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Accounts Payable And Accrued Liabilities Current NA 2357.90 NA NA NA 2074.20 NA NA NA 2206.80 NA NA NA 1521.80 NA NA NA 1086.80 NA NA NA 772.10 NA NA NA 815.08 818.43 716.36 1061.78 879.10 714.92 759.64 733.28 644.11 577.43 529.50 462.76 484.23 337.98 283.38 237.94 250.90 219.14 153.83 145.41 111.34 124.22 126.77 106.72 95.62 78.89 81.67 58.60 53.66 NA NA NA

Other Accrued Liabilities Current NA 666.70 NA NA NA 637.50 NA NA NA 383.90 NA NA NA 329.60 NA NA NA 301.30 NA NA NA 164.60 NA NA NA 129.41 84.69 79.37 99.05 103.51 83.46 107.03 102.64 85.64 126.07 72.20 97.88 117.30 55.68 48.54 38.11 29.02 38.32 19.95 22.37 19.57 22.20 15.22 18.20 14.13 8.21 7.81 NA 6.44 NA NA NA

Contract With Customer Liability Current 516.70 458.90 417.30 381.10 426.30 477.90 547.20 566.30 491.30 442.00 507.80 520.00 464.90 577.70 NA NA NA 591.70 NA NA NA 452.50 NA NA NA 320.10 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31

Long Term Debt Noncurrent 1983.30 1982.90 1982.60 1982.20 1981.80 1981.40 1981.10 1980.70 1980.40 1980.00 1979.60 1979.20 1978.90 1978.50 1978.30 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Other Liabilities Noncurrent 908.50 854.10 832.40 716.80 677.30 638.00 598.60 724.70 692.50 680.20 662.60 596.30 571.50 687.10 454.00 457.90 321.50 286.00 273.00 267.90 376.30 361.70 194.03 190.02 169.92 152.07 125.22 115.92 106.25 100.39 135.70 119.52 120.99 115.53 77.91 76.08 55.56 40.85 23.75 14.97 11.79 11.33 10.57 10.20 8.79 7.26 6.99 7.26 7.46 6.44 7.41 6.81 7.18 7.35 NA NA NA

Operating Lease Liability Noncurrent NA 68.70 NA NA NA 55.80 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31

Stockholders Equity 26991.10 25973.10 24904.40 24017.90 23495.20 22664.00 21438.80 20687.80 19914.70 18768.80 17258.00 15127.30 11977.00 11025.30 10125.50 9057.40 12133.00 11089.70 10504.40 9755.90 9444.70 8757.30 7868.30 7186.43 6567.64 6144.08 6051.59 5520.74 4866.02 4449.24 4491.25 4076.51 3765.08 3654.84 3296.87 3338.46 2971.43 2542.32 2551.79 2368.84 2211.25 1952.08 1690.17 1493.34 1406.35 1245.38 806.02 594.66 504.02 485.73 428.25 478.03 518.09 527.82 348.06 371.22 386.27

Additional Paid In Capital 11942.60 11354.00 11251.50 10888.50 10597.70 9949.30 9518.20 9120.20 8754.10 8087.50 7919.30 7225.80 6887.80 6716.20 6592.80 6263.00 5211.40 4428.60 4388.40 4263.60 4160.90 3911.60 3841.17 3712.60 3611.60 3512.83 3570.67 3449.62 3190.88 3029.99 3314.98 3156.94 3049.65 3099.53 2880.11 3118.97 2812.57 2404.12 2423.43 2342.84 2236.93 2045.86 1882.42 1827.47 1826.08 1763.51 1795.29 1775.86 1760.94 1754.82 1643.77 1630.36 1609.18 1575.78 NA NA NA

Retained Earnings Accumulated Deficit 27982.30 27260.30 26100.70 25092.90 24124.50 23306.70 22109.60 20793.90 19941.80 18968.30 16739.30 15107.10 12008.20 10893.00 9743.80 8901.70 8004.40 7379.80 6587.80 5918.20 5725.10 5254.30 4433.90 3839.18 3287.77 2946.73 2773.21 2384.90 1997.15 1748.22 1495.11 1230.30 1018.44 852.70 697.71 487.31 292.67 255.38 145.21 65.49 -27.25 -92.69 -189.50 -330.80 -418.18 -517.05 -987.46 -1178.93 -1255.67 -1267.32 -1213.88 -1151.52 -1089.01 -1045.56 NA NA NA

Accumulated Other Comprehensive Income Loss Net Of Tax -77.20 -80.90 -176.80 -197.70 -181.60 -238.80 -275.10 -223.80 -170.10 -26.20 9.50 15.70 16.20 29.30 30.80 35.50 -9.10 21.10 16.50 15.80 2.80 -12.30 -10.52 -11.61 -15.59 0.64 23.84 2.35 -5.88 -12.84 -2.90 5.20 4.36 8.57 7.72 19.15 47.90 52.25 26.89 4.26 1.47 -1.19 -2.85 -3.43 -1.64 -1.17 -1.90 -2.37 -1.34 -1.86 -1.73 -0.90 -2.17 -2.49 NA NA NA

Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 233.30 NA 207.40 208.00 237.40 NA 171.10 166.00 165.90 NA 136.40 135.90 135.60 NA 104.60 105.20 108.00 NA 112.70 109.20 114.80 NA 116.50 113.10 85.80 NA NA NA NA NA NA NA NA NA NA NA NA 82.61 74.56 72.16 82.98 55.29 46.08 45.17 53.55 30.67 20.66 19.40 23.45 15.84 13.38 12.49 14.90 NA NA NA 8.83

2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31

Net Cash Provided By Used In Operating Activities 1512.50 1089.70 1114.30 1022.40 1367.60 1719.90 628.90 564.40 2101.70 2372.50 3413.60 626.70 668.50 1231.00 -254.30 943.40 698.00 787.40 557.30 188.30 897.00 728.83 452.96 394.56 618.74 566.95 414.83 -30.57 355.90 377.88 651.03 415.15 29.34 281.82 892.85 243.61 -87.50 198.28 163.56 327.79 53.53 276.78 92.45 128.16 86.25 93.19 -2.38 -78.38 -87.04 -50.32 -46.73 -34.05 -10.58 -43.73 161.50 -11.85 -9.58

Net Cash Provided By Used In Investing Activities -1687.10 -66.20 -496.30 -2386.90 -235.70 -1857.70 192.30 -413.90 -1705.30 -2012.70 -2438.80 125.80 -1059.00 -305.00 -775.80 1453.40 -443.20 -208.70 -207.00 -836.00 -776.10 -265.91 -286.71 -484.97 -425.41 -335.75 -358.88 -170.41 -140.14 -271.36 -405.85 -326.01 -43.69 -123.30 -283.17 -371.65 -129.48 56.65 -123.07 -118.12 -236.23 -109.95 -214.45 116.63 -147.69 91.10 -48.75 -139.19 15.77 -33.91 -0.90 142.94 20.35 -351.74 50.17 3.82 -136.40

Net Cash Provided By Used In Financing Activities 47.10 -446.10 -407.30 -614.20 -322.50 -247.60 -725.00 -101.10 64.70 -906.60 385.40 -118.20 -366.40 -305.30 612.00 -2612.80 335.60 -345.70 -11.00 -15.30 119.90 -83.03 3.71 -11.21 13.43 -210.53 -8.20 133.52 60.81 -491.68 28.68 -46.84 -190.54 -4.01 -345.65 10.69 76.17 -252.76 5.93 -71.39 108.95 105.56 3.53 -43.48 11.52 -73.01 -1.81 -5.08 -17.75 361.44 -0.28 10.05 13.04 182.76 1.61 2.72 56.22

2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31

Net Cash Provided By Used In Operating Activities 1512.50 1089.70 1114.30 1022.40 1367.60 1719.90 628.90 564.40 2101.70 2372.50 3413.60 626.70 668.50 1231.00 -254.30 943.40 698.00 787.40 557.30 188.30 897.00 728.83 452.96 394.56 618.74 566.95 414.83 -30.57 355.90 377.88 651.03 415.15 29.34 281.82 892.85 243.61 -87.50 198.28 163.56 327.79 53.53 276.78 92.45 128.16 86.25 93.19 -2.38 -78.38 -87.04 -50.32 -46.73 -34.05 -10.58 -43.73 161.50 -11.85 -9.58

Net Income Loss 722.00 1159.60 1007.80 968.40 817.80 1197.10 1315.70 852.10 973.50 2229.00 1632.20 3098.90 1115.20 1149.20 842.10 897.30 624.60 792.00 669.60 193.10 461.10 820.40 594.65 551.41 477.98 173.52 388.32 387.74 248.93 253.12 264.80 196.22 165.74 154.99 210.40 194.64 76.02 110.18 79.72 92.73 65.44 96.81 141.31 87.38 98.87 470.41 191.47 76.74 11.65 -53.44 -62.37 -62.51 -43.45 -14.60 -33.88 -25.47 -30.52

Depreciation Depletion And Amortization 114.10 113.00 105.40 103.10 99.50 100.10 92.60 74.40 74.30 74.50 73.20 71.10 67.40 61.70 59.30 58.80 56.10 54.30 52.90 52.10 51.00 42.76 35.44 33.64 36.36 34.51 37.72 35.13 38.12 28.90 27.84 25.03 22.98 22.91 20.67 15.30 16.03 14.13 14.01 13.02 11.53 11.29 10.80 9.70 9.41 9.78 9.33 9.42 8.42 7.94 8.28 7.90 6.98 6.09 4.89 4.52 4.18

Increase Decrease In Accounts Receivable -446.80 82.70 463.50 2.70 -210.10 -219.60 386.90 322.40 -1197.50 584.50 -1541.00 2825.60 58.30 80.80 1228.20 -121.90 169.00 12.20 204.10 150.70 106.10 40.30 163.70 95.31 -30.41 2.89 126.90 95.00 137.93 -32.25 -108.10 -113.25 397.43 28.48 44.19 97.69 321.06 90.14 33.33 -153.57 92.53 -101.05 116.81 73.38 109.52 91.85 165.89 197.03 135.31 35.78 -6.12 -3.59 -4.96 10.82 -12.91 23.34 6.29

Increase Decrease In Inventories 155.80 47.30 77.20 100.40 46.80 144.30 223.50 240.10 88.60 163.70 109.10 -31.30 252.80 127.00 169.00 162.60 70.80 108.30 59.00 109.60 58.60 106.28 99.52 93.34 88.76 78.55 84.10 81.80 69.74 50.07 26.82 10.62 62.26 30.37 31.61 43.92 5.93 9.98 13.62 21.75 15.55 11.21 5.60 13.56 17.58 NA NA NA NA NA NA NA NA NA NA NA NA

Share Based Compensation 230.10 240.40 203.90 202.00 238.70 232.00 166.30 159.80 166.90 188.40 136.90 145.50 130.90 121.50 101.20 103.50 105.80 133.50 117.10 105.80 107.90 126.75 111.44 106.80 82.42 127.13 125.10 121.26 133.79 154.56 131.38 131.69 142.25 158.39 102.60 94.26 103.76 81.45 68.10 64.83 81.41 55.18 45.74 44.44 53.03 30.77 20.54 19.61 23.24 15.53 13.36 12.40 14.80 13.57 8.79 8.71 8.83

2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31

Net Cash Provided By Used In Investing Activities -1687.10 -66.20 -496.30 -2386.90 -235.70 -1857.70 192.30 -413.90 -1705.30 -2012.70 -2438.80 125.80 -1059.00 -305.00 -775.80 1453.40 -443.20 -208.70 -207.00 -836.00 -776.10 -265.91 -286.71 -484.97 -425.41 -335.75 -358.88 -170.41 -140.14 -271.36 -405.85 -326.01 -43.69 -123.30 -283.17 -371.65 -129.48 56.65 -123.07 -118.12 -236.23 -109.95 -214.45 116.63 -147.69 91.10 -48.75 -139.19 15.77 -33.91 -0.90 142.94 20.35 -351.74 50.17 3.82 -136.40

Payments To Acquire Productive Assets 133.90 251.40 176.00 113.00 178.20 152.20 142.50 153.60 141.80 154.90 133.20 148.50 115.30 161.40 153.20 129.90 170.10 139.00 121.70 94.60 74.30 85.46 106.25 112.02 79.38 107.66 59.65 54.85 50.46 150.46 118.56 138.84 104.09 177.78 146.10 239.89 114.16 117.54 79.77 70.87 64.82 68.98 31.69 34.45 21.20 15.16 10.25 12.87 11.05 11.29 8.90 14.86 22.17 32.26 22.10 22.58 22.74

2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31

Net Cash Provided By Used In Financing Activities 47.10 -446.10 -407.30 -614.20 -322.50 -247.60 -725.00 -101.10 64.70 -906.60 385.40 -118.20 -366.40 -305.30 612.00 -2612.80 335.60 -345.70 -11.00 -15.30 119.90 -83.03 3.71 -11.21 13.43 -210.53 -8.20 133.52 60.81 -491.68 28.68 -46.84 -190.54 -4.01 -345.65 10.69 76.17 -252.76 5.93 -71.39 108.95 105.56 3.53 -43.48 11.52 -73.01 -1.81 -5.08 -17.75 361.44 -0.28 10.05 13.04 182.76 1.61 2.72 56.22

Payments For Repurchase Of Common Stock 291.30 289.00 546.50 688.80 710.70 431.10 934.60 359.00 358.10 866.90 166.40 305.20 306.90 381.10 92.10 5052.90 320.70 246.50 19.40 0.00 10.00 0.02 4.38 0.00 0.00 0.00 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31

Revenues 3145.00 3434.30 3362.70 3158.10 3162.10 3414.40 2936.20 2857.20 2965.10 4951.70 3452.80 5138.50 2528.70 2422.90 2294.00 1952.00 1828.20 2169.50 2048.40 1933.70 1711.80 1927.80 1663.50 1608.02 1511.48 1582.45 1500.67 1470.12 1318.99 1226.83 1220.12 1212.63 1200.85 1098.08 1137.42 998.62 869.61 802.33 725.79 665.70 625.74 610.41 597.03 457.64 439.66 414.60 427.69 304.40 231.79 122.98 102.83 107.81 112.20 133.68 105.98 115.89 103.53

Revenue From Contract With Customer Excluding Assessed Tax 3145.00 3434.30 3362.70 3158.10 3162.10 3414.40 2936.20 2857.20 2965.10 4951.70 3452.80 5138.50 2528.70 2422.90 2294.00 1952.00 1828.20 2169.50 2048.40 1933.70 1711.80 1927.80 1663.50 1608.02 1511.50 1582.40 1500.67 1470.12 1319.00 1226.83 1220.12 1212.63 1200.85 1098.08 1137.42 998.62 869.61 802.33 725.79 665.70 625.74 610.41 597.03 457.64 439.66 414.60 427.69 304.40 231.79 122.98 102.83 107.81 112.20 133.68 105.98 115.89 103.53

Collaboration Revenue 1266.80 1370.00 1438.30 1316.70 1378.10 -1268.30 1050.60 1043.60 1232.50 -1011.90 1073.90 954.70 754.40 -508.70 653.20 513.30 528.30 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Inmazeb 1.00 NA NA NA 2.20 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

L I B T A Y O Net Product Sales 263.90 NA NA NA 176.90 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Product 1761.30 1851.80 1786.10 1772.10 1668.00 1699.30 1801.40 1754.40 1638.60 3975.20 2279.90 4137.80 1724.30 1621.80 1482.20 1226.90 1236.70 1286.40 1238.30 1205.30 1104.40 1096.42 1025.49 996.38 987.90 978.75 957.37 924.13 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Product And Service Other 116.90 212.50 138.30 69.30 116.00 127.70 84.20 59.20 94.00 86.20 99.00 46.00 50.00 123.40 158.60 211.80 63.20 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Other, Roche Collaboration Agreement, Collaboration Revenue NA -3.80 -5.70 -3.80 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Reimbursement For Manufacturing Of Commercial Supplies, Sanofi Collaboration Agreement Antibody, Collaboration Revenue 105.80 107.00 151.50 192.60 161.90 166.90 160.50 145.50 160.80 127.60 144.70 110.90 105.60 93.00 94.30 100.60 80.10 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Reimbursement Of Commercialization Related Expenses, Sanofi Collaboration Agreement Antibody, Selling General And Administrative Expenses 139.50 150.40 135.50 130.90 117.60 126.30 108.60 110.80 91.70 103.60 79.00 78.30 60.40 99.00 83.20 86.00 91.20 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Reimbursement Of Research And Development Expenses Net Of Obligation For Share Of R D Expenses, Sanofi Collaboration Agreement Antibody, Research And Development Expense -18.60 -17.00 -25.80 -14.50 -26.40 -16.60 -4.30 37.10 26.80 39.70 34.90 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Ronapreve, Roche Collaboration Agreement, Collaboration Revenue 0.50 2.10 0.00 0.00 222.20 396.40 6.40 8.20 216.30 0.00 127.10 167.90 66.80 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Sales Based Milestone Earned, Sanofi Collaboration Agreement Antibody, Collaboration Revenue NA 0.00 50.00 NA NA 50.00 0.00 0.00 50.00 0.00 50.00 NA NA 0.00 50.00 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Share Of Profit Losses In Connection With Commercialization, Sanofi Collaboration Agreement Antibody, Collaboration Revenue 804.00 NA 863.00 751.10 636.50 NA 551.10 496.60 415.30 NA 387.00 327.60 260.60 NA 212.80 171.90 170.90 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

ELYEAHD,US 200.00 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

E L Y E A H D And E Y L E A,US 1401.60 NA NA NA 1433.80 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Evkeeza,US 24.80 24.00 19.10 19.30 14.90 15.40 13.60 11.10 8.50 9.30 6.60 2.00 0.50 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Eylea Net Product Sales,US 1201.60 1337.50 1448.20 1500.10 1433.80 1496.40 1629.40 1621.20 1517.60 1547.20 1473.40 1424.70 1347.00 1343.20 1318.30 1113.70 1172.00 1222.10 1187.70 1160.30 1074.10 1078.87 1021.78 992.00 984.00 974.77 953.28 919.47 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Inmazeb,US NA 62.10 3.30 2.20 2.20 0.00 3.00 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

L I B T A Y O Net Product Sales,US 159.20 154.80 144.10 130.20 109.70 110.00 94.70 90.90 78.90 80.80 78.40 78.00 69.10 74.10 71.60 63.30 61.70 60.50 47.60 40.80 26.80 14.80 0.00 0.00 0.00 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

L I B T A Y O Net Product Sales, Non Us 104.70 NA NA NA 67.20 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Praluent Net Product Sales,US 70.00 61.30 40.40 40.50 40.20 35.50 29.70 31.20 33.60 40.00 44.80 41.90 43.30 55.20 48.50 47.20 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Net Profit In Connection With Commercialization, Non Us, Bayer Collaboration Agreement, Collaboration Revenue 333.90 345.40 349.90 349.50 331.60 324.00 315.30 339.70 338.40 353.90 351.00 335.40 308.90 335.30 287.90 230.90 253.80 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Regenerons Obligation Of Research And Development Expenses Net Of Reimbursement Of Research And Development Expenses, Non Us, Bayer Collaboration Agreement, Research And Development Expenses And Reduction Of Research And Development Expense -8.70 -8.90 -9.70 -12.00 -13.40 6.40 7.10 2.90 0.30 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Reimbursement For Manufacturing Of Commercial Supplies, Non Us, Bayer Collaboration Agreement, Collaboration Revenue 22.10 31.40 27.20 27.20 25.30 31.10 17.50 17.80 25.00 18.50 14.00 13.70 13.90 25.30 12.00 13.30 27.60 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Plots across concepts

IncomeStatement

Other Comprehensive Income Loss Net Of Tax

Expenses

Other Nonoperating Income Expense

Balance Sheet

Operating Lease Right Of Use Asset

Assets

Operating Lease Right Of Use Asset

Current Assets

Prepaid Expense And Other Assets Current

NonCurrent Assets

Operating Lease Right Of Use Asset

Liabilities

Operating Lease Liability

Current Liabilities

Operating Lease Liability Current

Noncurrent Liabilities

Operating Lease Liability Noncurrent

Stockholders Equity

Accumulated Other Comprehensive Income Loss Net Of Tax

CashFlow

Net Cash Provided By Used In Investing Activities

NetCashProvidedByUsedInOperatingActivities

Increase Decrease In Accounts Receivable

NetCashProvidedByUsedInInvestingActivities

Net Cash Provided By Used In Investing Activities

NetCashProvidedByUsedInFinancingActivities

Net Cash Provided By Used In Financing Activities

Shares

Weighted Average Number Of Shares Outstanding Basic

OperatingLeaseLiability

Operating Lease Liability Current

NonoperatingIncomeExpense

Nonoperating Income Expense

LesseeOperatingLeaseLiabilityPaymentsDue

Lessee Operating Lease Liability Payments Due Year Four

FiniteLivedIntangibleAssets

Finite Lived Intangible Assets Accumulated Amortization

InventoryNet

Inventory Finished Goods Net Of Reserves

Line plots across dimensions of each concept